| 000 | 01833 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514220952.0 | ||
| 264 | 0 | _c20050317 | |
| 008 | 200503s 0 0 eng d | ||
| 022 | _a0022-3085 | ||
| 024 | 7 |
_a10.3171/jns.2005.102.2.0216 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSlevin, John T | |
| 245 | 0 | 0 |
_aImprovement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. _h[electronic resource] |
| 260 |
_bJournal of neurosurgery _cFeb 2005 |
||
| 300 |
_a216-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aDominance, Cerebral _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGait _xdrug effects |
| 650 | 0 | 4 | _aGlial Cell Line-Derived Neurotrophic Factor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusion Pumps, Implantable |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aNerve Growth Factors _xadministration & dosage |
| 650 | 0 | 4 |
_aParkinson Disease _xdiagnosis |
| 650 | 0 | 4 |
_aPostural Balance _xdrug effects |
| 650 | 0 | 4 |
_aPsychomotor Performance _xdrug effects |
| 650 | 0 | 4 |
_aPutamen _xdrug effects |
| 650 | 0 | 4 |
_aReaction Time _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGerhardt, Greg A | |
| 700 | 1 | _aSmith, Charles D | |
| 700 | 1 | _aGash, Don M | |
| 700 | 1 | _aKryscio, Richard | |
| 700 | 1 | _aYoung, Byron | |
| 773 | 0 |
_tJournal of neurosurgery _gvol. 102 _gno. 2 _gp. 216-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3171/jns.2005.102.2.0216 _zAvailable from publisher's website |
| 999 |
_c15413660 _d15413660 |
||